<DOC>
	<DOCNO>NCT02040974</DOCNO>
	<brief_summary>Our aim evaluate effectiveness subcutaneous allergen immunotherapy symptom score ( RSS ) , visual analog scale ( VAS ) medication score ( MS ) impact quality life rhinoconjunctivitis quality life questionnaire ( RQLQ ) allergic rhinitis patient sensitize different allergen . Also development new sensitization asthma immunotherapy determine .</brief_summary>
	<brief_title>Allergen Immunotherapy Allergic Patients</brief_title>
	<detailed_description>Allergic rhinitis patient sensitize least one common aero-allergen complete three five year period allergen immunotherapy outpatient clinic 2002-2013 enrol study patient allergic rhinitis receive medical treatment choose control group . Patients separate two group accord sensitization pattern include pollen house dust mite . All patient evaluate immunotherapy , first fifth year treatment two year treatment .</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<criteria>allergic rhinitis/asthma pregnancy , malignity , autoimmunity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>immunotherapy , house dust mite , pollen , allergic rhinitis</keyword>
</DOC>